Unmet Needs And Niche Markets: These Pharma Stocks Have The Momentum

While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s article advises that “companies working on pharmaceutical products for unmet needs or other niche markets such as animal health could be worth a closer look” – and he’s got the charts for two such stocks poised to move higher to back up his claim. For more, CLICK HERE.